Blueprint Medicines Ownership | Who Owns Blueprint Medicines?
Blueprint Medicines Ownership Summary
Blueprint Medicines is owned by 101.09% institutional investors, 0.88% insiders. Vanguard group is the largest institutional shareholder, holding 10.69% of BPMC shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.23% of its assets in Blueprint Medicines shares.
BPMC Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Blueprint Medicines | 101.09% | 0.88% | -1.97% |
Sector | Healthcare Stocks | 486.50% | 11.08% | -397.59% |
Industry | Biotech Stocks | 304.14% | 11.08% | -215.23% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Vanguard group | 6.77M | 10.69% | $590.91M |
Blackrock | 6.65M | 10.58% | $716.45M |
Blackrock funding, inc. /de | 6.12M | 9.62% | $784.26M |
Price t rowe associates inc /md/ | 5.68M | 8.96% | $495.33M |
Wellington management group llp | 4.28M | 6.75% | $373.42M |
Pentwater capital management lp | 3.90M | 6.13% | $499.90M |
State street | 2.50M | 3.94% | $218.07M |
Fmr | 2.25M | 3.55% | $196.04M |
Fil | 1.76M | 2.77% | $225.53M |
Ubs oconnor | 1.71M | 2.69% | $219.65M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Syquant capital sas | 805.60K | 34.24% | $103.26M |
Aquilo capital management | 83.93K | 13.32% | $7.43M |
Ubs oconnor | 1.71M | 11.25% | $219.65M |
Twin securities | 120.13K | 8.74% | $15.40M |
Trium capital llp | 240.10K | 7.66% | $30.78M |
Alpine associates management | 1.06M | 7.25% | $135.91M |
Glazer capital | 1.33M | 6.10% | $170.65M |
Dafna capital management | 168.76K | 5.97% | $21.63M |
Kryger capital | 248.22K | 5.89% | $31.82M |
Chicago capital management | 60.00K | 5.65% | $7.69M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Pentwater capital management lp | 3.90M | 3.24% | 3.90M |
Fil | 1.76M | 0.19% | 1.76M |
Ubs oconnor | 1.71M | 11.25% | 1.70M |
Glazer capital | 1.33M | 6.10% | 1.33M |
Alpine associates management | 1.06M | 7.25% | 1.06M |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Avoro capital advisors | 375.00K | 0.84% | -3.48M |
Fmr | 2.25M | 0.01% | -2.27M |
William blair investment management | 8.57K | 0.00% | -1.42M |
T. rowe price investment management | - | - | -1.30M |
Alkeon capital management | - | - | -900.63K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Pentwater capital management lp | 3.90M | 3.24% | 3.90M | $499.90M |
Fil | 1.76M | 0.19% | 1.76M | $225.53M |
Glazer capital | 1.33M | 6.10% | 1.33M | $170.65M |
Alpine associates management | 1.06M | 7.25% | 1.06M | $135.91M |
Davidson kempner capital management lp | 1.04M | 2.19% | 1.04M | $132.68M |
Sold Out
Holder | Change |
---|---|
Tfc financial management | -1.00 |
National bank of canada /fi/ | -1.00 |
Td private client wealth | -2.00 |
American capital advisory | -3.00 |
Quadrant capital group | -3.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2025 | 374 | 1.63% | 64,295,614 | -6.16% | 101 | 0.87% | 206 | 5.10% | 114 | -0.87% |
Mar 31, 2025 | 19 | -94.78% | 3,679,558 | -94.53% | 5 | 0.05% | 12 | -94.15% | 5 | -95.05% |
Dec 31, 2024 | 362 | 5.23% | 67,270,926 | 3.92% | 106 | 1.02% | 202 | 2.02% | 102 | 21.43% |
Sep 30, 2024 | 339 | 3.04% | 64,638,237 | -2.28% | 101 | 0.92% | 196 | 17.37% | 83 | -17.82% |
Jun 30, 2024 | 329 | 7.17% | 66,148,228 | 1.60% | 105 | 0.94% | 167 | 8.44% | 101 | 9.78% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard Total Stock Mkt Idx Inv | 2.09M | 3.23% | 39.02K |
Vanguard US Total Market Shares ETF | 2.00M | 3.13% | 1.81K |
iShares Russell 2000 ETF | 1.60M | 2.47% | 11.11K |
Vanguard Small Cap Index | 1.58M | 2.44% | -33.77K |
Vanguard Health Care Inv | 1.36M | 2.11% | -727.09K |
Vanguard Institutional Extnd Mkt Idx Tr | 996.08K | 1.54% | 306.00 |
Delaware Small Cap Core I | 908.17K | 1.43% | -5.63K |
Vanguard Small Cap Growth Index Inv | 885.23K | 1.37% | -2.86K |
JPMorgan Growth Advantage A | 770.25K | 1.19% | -4.80K |
T. Rowe Price Integrated US SmCapGrEq | 734.32K | 1.16% | 367.16K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Jul 03, 2025 | Rossi Christina | CHIEF OPERATING OFFICER | Sell | $150.31K |
Jul 03, 2025 | Carter Percy H. | CHIEF SCIENTIFIC OFFICER | Sell | $134.79K |
Jun 03, 2025 | Carter Percy H. | CHIEF SCIENTIFIC OFFICER | Sell | $30.82K |
Jun 03, 2025 | Carter Percy H. | CHIEF SCIENTIFIC OFFICER | Sell | $309.21K |
May 27, 2025 | Albers Jeffrey W. | - | Sell | $439.44K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q2 | - | 18 |
2025 Q1 | - | 32 |
2024 Q4 | - | 18 |
2024 Q3 | - | 6 |
2024 Q2 | - | 21 |
BPMC Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools